Related Articles

• Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast‑enhanced magnetic resonance imaging
• Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast‑enhanced MRI
• Quantitative analysis of permeability for glioma grading using dynamic contrast‑enhanced magnetic resonance imaging
• Application evaluation of DCE‑MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer
• Dynamic contrast enhanced‑magnetic resonance imaging for the early evaluation of the response to docetaxel in rats with epithelial ovarian cancer